Dexmedetomidine-esketamine-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia

Phase 4 Completed 300 enrolled Peking University First Hospital

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Sufentanil-ropivacaine combination is commonly used for epidural labor anesthesia, but is associated with some adverse events. Dexmedetomidine and esketamine, each has been effectively used for neuraxial anesthesia in combination with local anesthetics. Plenty of evidences show that both dexmedetomidine and esketamine, combined with ropivacaine, are also effective as the sufentanil-ropivacaine combination when used for epidural labor analgesia. This pilot trial is designed to evaluate the efficacy and safety of the dexmedetomidine-esketamine-ropivacaine versus sufentanil-ropivacaine combination for epidural labor analgesia, and to test the feasibility of a future large randomized trial.

Timeline

Start: 2025-09-05
Primary completion: 2026-01-29
Completion: 2026-03-13

Publications

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dexmedetomidine	Other / unclassified	0.4 ug/ml	Other
Subject	Esketamine	Other / unclassified	0.15 mg/ml	Other
Subject	Esketamine	Other / unclassified	0.2 mg/ml	Other
Subject	Ropivacaine	Other / unclassified	0.036 %	Other
Subject	Ropivacaine	Other / unclassified	0.072 %	Other
Comparator	Sufentanil	Other / unclassified	0.4 ug/ml	Other

Indications

No indication recorded.